William Raines - Mar 12, 2021 Form 4/A - Amendment Insider Report for cbdMD, Inc. (YCBD)

Role: Director
Signature: /s/ William Raines III
Stock symbol: YCBD
Transactions as of: Mar 12, 2021
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 10/5/2021, 01:42 PM
Date Of Original Report: Mar 16, 2021
Next filing: Apr 19, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	YCBD	Common stock	Award	$0	+5K	+372.58%	$0.00	6.34K	Mar 12, 2021	Direct	F1
holding	YCBD	Common stock						3.77M	Mar 12, 2021	See footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly in equal increments over a one year period from the grant date with the last vesting being on March 12, 2022, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.
F2	The number of shares of common stock beneficially owned by the Reporting Person includes: (i) 92,582 shares held of record by Board Investor Group II, LLC; and (ii) 3,682,000 Second Tranche Shares for which unrestricted voting rights have not yet vested. Mr. Raines, in his position as Chief Executive Officer of Board Investor Group II, LLC, has voting and dispositive control over securities held by Board Investor Group II, LLC. Mr. Raines disclaims beneficial ownership of securities held by Board Investors Group II, LLC except to the extent of his pecuniary interest therein, and disclaims beneficial ownership of the 3,682,000 Second Tranche Shares which are subject to the Voting Proxy agreements.

Content

Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly in equal increments over a one year period from the grant date with the last vesting being on March 12, 2022, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

The number of shares of common stock beneficially owned by the Reporting Person includes: (i) 92,582 shares held of record by Board Investor Group II, LLC; and (ii) 3,682,000 Second Tranche Shares for which unrestricted voting rights have not yet vested. Mr. Raines, in his position as Chief Executive Officer of Board Investor Group II, LLC, has voting and dispositive control over securities held by Board Investor Group II, LLC. Mr. Raines disclaims beneficial ownership of securities held by Board Investors Group II, LLC except to the extent of his pecuniary interest therein, and disclaims beneficial ownership of the 3,682,000 Second Tranche Shares which are subject to the Voting Proxy agreements.

Remarks:

The original Form 4 filed on March 16, 2021 is amended by this Form 4 to disclose the restricted stock units as a non-derivative security. No other changes have been made to the original Form 4.